5 FU bolus Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Also known as: 5 FU, fluorouracil

Pipeline

Phase 3: 2

Top Sponsors

Sun Yat-sen University1
Federation Francophone de Cancerologie Digestive1

Indications

Colorectal Neoplasms2
Cancer2
Liver Disease1
Intestinal Neoplasms1
Digestive System Neoplasms1

Other2 trials

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Phase 3

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.